CHRISTOPHER O'CARROLL: Open Payments
NPI 1720187487 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46,787 in 273 payments from 26 companies in 2025. Trend: 2023 $57,230 · 2024 $30,765 · 2025 $46,787
Honoraria: $25,539Speaker / faculty: $11,550Food & beverage: $6,982Consulting: $2,528Education: $101Travel & lodging: $87
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 32 | $21,425 |
| PFIZER INC. | 34 | $9,069 |
| ABBVIE INC. | 91 | $7,455 |
| Lundbeck LLC | 13 | $6,140 |
| UCB, Inc. | 27 | $708 |
| Alexion Pharmaceuticals, Inc. | 12 | $331 |
| Teva Pharmaceuticals USA, Inc. | 7 | $254 |
| Neurocrine BioSciences, Inc. | 10 | $233 |
| LivaNova USA, Inc. | 4 | $223 |
| Eisai Inc. | 7 | $153 |
Products named: Symbravo, NURTEC ODT, QULIPTA, VYEPTI, BOTOX, Rystiggo, Auvelity, ULTOMIRIS.
Industry payments across CA — which companies pay providers there.
